Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Intensive care unit" wg kryterium: Temat


Wyświetlanie 1-5 z 5
Tytuł:
Association of glycosylated hemoglobin with mortality of patients in intensive care unit: a prospective observation study
Autorzy:
Kumar, Damera Seshi
Wasnik, Seema Balkrishna
Yadav, Amlendu
Yadav, Rupesh
Powiązania:
https://bibliotekanauki.pl/articles/29432036.pdf
Data publikacji:
2024-03-31
Wydawca:
Towarzystwo Pomocy Doraźnej
Tematy:
Glycated hemoglobin
intensive care unit
mortality
Opis:
INTRODUCTION: Glycated hemoglobin (HbA1c) is the most commonly used clinical test to estimate mean blood glucose during the past 2 to 3 months. In addition to diagnostic purposes, the HbA1c level also predicts diabetes complications. The aim of this study was to determine the association of glycosylated hemoglobin with mortality in intensive care unit (ICU). MATERIALS AND METHODS: A prospective observational study was conducted in the ICU with a total of 281 patients. These patients were classified into two groups based on their HbA1c levels: one group with HbA1c level < 6.5 % and another group with HbA1c level ≥ 6.5%. The following data were collected during the study period. Clinical details and scores such as the APACHE II score (Acute Physiology and Chronic Health Assessment) and daily SOFA (Sequential Organ Failure Assessment) scores for the period of stay in the ICU. ICU morbidities as the need for mechanical ventilation, the use of inotropes / vasopressors, the length of stay in the ICU, and the requirement of renal replacement therapy (RRT). The outcome measures were ICU mortality and 28-day mortality. RESULTS: Of 281 patients admitted to the ICU for more than 48 hours, 157 patients (55.9%) had HbA1c levels < 6.5%, with the remaining 124 (44.1%) had levels ≥ 6.5%. ICU mortality was present in 107 (38.07%) cases. ICU mortality was higher in patients in the HbA1c ≥ 6.5% group compared to the HbA1c < 6.5% group. This was statistically significant (p-value <0.001). Mortality at 28 days was observed in 125 (44.48%) cases. Patients with an HbA1c value ≥ 6.5%, there was a higher mortality at 28 days compared to patients with an HbA1c value < 6.5%. This was found to be statistically significant (p-value <0.001). CONCLUSIONS: The study showed that glycated hemoglobin levels (HbA1c) levels ≥ 6.5% had a significantly higher mortality rate compared to the patient in the HbA1c level < 6.5%.
Źródło:
Critical Care Innovations; 2024, 7, 1; 24-33
2545-2533
Pojawia się w:
Critical Care Innovations
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Correlation of vitamin D deficiency with mortality in critically ill patients admitted to the intensive care unit
Autorzy:
Joshi, Vidit Maheshkumar
Wasnik, Seema Balkrishna
Yadav, Amlendu
Yadav, Rupesh
Powiązania:
https://bibliotekanauki.pl/articles/29432042.pdf
Data publikacji:
2024-03-31
Wydawca:
Towarzystwo Pomocy Doraźnej
Tematy:
Intensive care unit
mortality
vitamin D
Opis:
INTRODUCTION: Vitamin D, which is a fat-soluble vitamin, plays a key role in enhancing the intestinal absorption of calcium, magnesium and phosphate. In severely ill patients, vitamin D can adversely affect immune and metabolic functions, contributing to poorer outcomes. The aim of this study was to correlate vitamin D with mortality in critically ill patients. MATERIALS AND METHODS: prospective observational study was conducted, involving 162 patients in an intensive care unit (ICU). 162 patients were divided into two groups according to vitamin D Deficiency Group levels ≤ 20 ng/ml and Non vitamin D deficiency group levels <20 ng / ml and non-vitamin D deficiency group B levels > 20ng/ml. Data collected during the study included the APACHE II (acute physiology and chronic health evaluation) score at ICU admission, SOFA (sequential organ failure assessment) scores throughout the ICU stay, the need for mechanical ventilation, inotropic support, length of stay in ICU, and ICU outcomes, which were classified as either discharge or mortality. RESULTS: Of the 162 patient admitted to ICU, the prevalence of vitamin D deficiency in this study was 140 (86.4%) and nondeficient 22 (13.6%). The mortality rate in the vitamin D deficient group was 40% compared to 18.18% in the nondeficient group. The difference in mortality in both groups for mortality was statistically significant (p-value < 0.05). Vitamin D deficiency was not associated as an independent risk factor for ICU mortality [Odds ratio (OR) 1.220, 95% CI (0.825- 1.805) (p-value -0.320)]. CONCLUSIONS: The vitamin D-deficient group had a significantly higher mortality rate compared to the patient in the nondeficient group. But vitamin D deficiency was not found to be an independent risk factor for mortality.
Źródło:
Critical Care Innovations; 2024, 7, 1; 1-11
2545-2533
Pojawia się w:
Critical Care Innovations
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Acute hypersensitivity reaction following intravenous ferric carboxymaltose injection for iron deficiency anaemia: a case report
Autorzy:
Kumar, Neeraj
Gautam, Preeti Bala
Ahmad, Sarfaraz
Qutub, Danish
Prasad, Indira
Powiązania:
https://bibliotekanauki.pl/articles/29432056.pdf
Data publikacji:
2023
Wydawca:
Towarzystwo Pomocy Doraźnej
Tematy:
Ferric carboxy maltose
hypersensitivity reaction
intensive care unit
Opis:
Ferric carboxymaltose (FCM) is a non-dextran iron preparation used for intravenous treatment of iron deficiency anaemia (IDA) in adult patients with intolerance or poor response to oral iron therapy. Acute hypersensitivity reactions (HSRs) during iron infusions are very rare but can be life-threatening even after receiving a prior test dose. Here, we report a case of 42 years old female patient who underwent total laparoscopic hysterectomy with bilateral salpingo-oophorectomy. On the next postoperative day she received an injection of ferric carboxy maltose. She was diagnosed with IDA. She presented with the picture of an adverse drug reaction due to injection FCM. She was managed with oxygen, vasopressors, antihistaminics, intravenous fluids and, corticosteroids. She recovered well within 24 hours of intensive care unit admission following this adverse drug reaction. So, careful and precise observation is required in management of adverse reaction following ferric carboxymaltose and prompt recognition and treatment based on severity is warranted.
Źródło:
Critical Care Innovations; 2023, 6, 1; 41-45
2545-2533
Pojawia się w:
Critical Care Innovations
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Acute naphthalene toxicity following ingestion of mothballs and ethyl alcohol: a case report
Autorzy:
Roshan, Nikesh Kumar
Vishwas, Kirti
Kumar, Neeraj
Powiązania:
https://bibliotekanauki.pl/articles/29432052.pdf
Data publikacji:
2023
Wydawca:
Towarzystwo Pomocy Doraźnej
Tematy:
Naphthalene balls
mothballs
ethyl alcohol
toxicity
intensive care unit
Opis:
Naphthalene poisoning is an uncommon poisoning due to its pungent smell, taste, insolubility in water, and poor absorption from the gut following exposure to naphthalene-containing compounds such as mothballs. Paradichlorobenzene has been reported to dissolve more quickly in alcohol. Within a period of 48-96 hours following naphthalene mothball exposure patient presents with acute onset of non-bloody bilious vomiting, dark brown urine and watery diarrhoea. We present a diagnostic and therapeutic challenge while treating a 27 years old male admitted to the intensive care unit with features of acute naphthalene-toxicity, methemoglobinemia and acute kidney injury following accidental ingestion of mothballs and ethyl alcohol. His vital signs at the time of intensive care unit admission included fever, tachycardia, and hypotension, and his laboratory workup demonstrates hyperbilirubinemia with indirect predominance, hemolytic anaemia, methemoglobinemia, and renal dysfunction. Treatment options include supportive care, red cell transfusion, ascorbic acid, methylene blue, and N-acetylcysteine. The importance of obtaining a careful history and clinical findings is of paramount importance, especially in making the right diagnosis and a successful outcome largely depends on it.
Źródło:
Critical Care Innovations; 2023, 6, 1; 29-35
2545-2533
Pojawia się w:
Critical Care Innovations
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Evaluation of patients with candida infections in a tertiary care hospital’s general intensive care unit in Turkey.
Autorzy:
Ceylan, İlkay
Korkmaz, Hamide Ayben
Karakoç, Ebru
Powiązania:
https://bibliotekanauki.pl/articles/2054911.pdf
Data publikacji:
2022-06-30
Wydawca:
Towarzystwo Pomocy Doraźnej
Tematy:
Candidemia
sepsis
non-albicans
intensive care unit
candida species
Opis:
INTRODUCTION: : Studies indicate that approximately 90% of the patients followed in the ICU have Candida spp colonization. In this study we aimed to elucidate the epidemiology, characteristics, management and outcomes of patients with candidemia in the intensive care unit of a training and research hospital. MATERIAL AND METHODS: All patients over the age of 18 who were hospitalized in general intensive care unit more than 24 hours between 2013 and 2019 were included in the this retrospective study. RESULTS: A total of 43 critically ill patients with blood cultures positive for Candida spp. have been enrolled in this retrospective analysis. The duration of stay in the intensive care unit of the survivors was approximately 53 days, while the average length of stay in the intensive care unit of the non survivors was 16 days, and this difference was statistically significant (p<0.05), 89.7% of septic patients with candidemia died the intensive care unit. There was a statistically significant difference between the two groups in terms of platelets, urea and systolic blood pressure (p<0.05), the mean platelet and systolic blood pressure values of the surviving patients were higher than the deceased individuals, while the urea value was lower. The average fungal growth time of the surviving individuals was 17 days, while this period was 1 day in the non-survivor patients. CONCLUSIONS: The mortality rate was higher in patients with sepsis and concomittant candida infection at very soon days of ICU hospitalization. Early administration of empirical antifungal therapy with coverage of non-albicans should be considered for septic patients.
Źródło:
Critical Care Innovations; 2022, 5, 2; 1-10
2545-2533
Pojawia się w:
Critical Care Innovations
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies